2009 DOM Annual Report - Department of Medicine - University of ...

More documents

Recommendations

Info

Department of MedicineHIGH IMPACT PUBLICATIONSDr. Ridgway and colleagues (Diabetes 56:186-196, 2007) demonstrated that treatment of nonobese diabetic (NOD) mice, an animal model ofspontaneous Type one diabetes (T1D), with an agonist anti-CD137 antibody prevented diabetes. The mechanism of protection was specificallymediated by CD4+CD25+CD137+ T regulatory cells. This research is important because candidate genes in NOD diabetes have often been foundin human diabetes.Dr. Ascherman and colleagues (Journal of Autoimmunity 29:174-186, 2007) continue to study the role of Jo-1 directed B and T cell responsesin different genetic backgrounds of animal models (C57BL/6 and NOD congenic mice). This animal model of myositis provides a uniqueopportunity for elucidating the mechanisms of this immune-mediated muscle disease.Dr. Wasko and colleagues (JAMA 298:187-193, 2007) reported from a study evaluating patients with rheumatoid arthritis the role ofhydroxychloroquine in preventing or reducing the risk of diabetes. These finding provide the framework for defining additional mechanisms ofaction of this commonly used arthritis medication.A major research focus in the Lupus Center of Excellence is the dramatic 50-fold increased risk of myocardial infarction observed in youngwomen with lupus. Research progress in this field has been hampered by the lack of an informative animal model that can be used tounderstand the mechanisms of this process and to develop effective therapies. Investigators in the Lupus Center of Excellence, in collaborationwith the McGowan Institute for Regenerative Medicine, the Center for Vascular Remodeling and Regeneration, and the Department ofBioengineering have recently reported successful development of the first experimental model for ex vivo investigation of vascular stiffness andatherosclerosis in a mouse model. This multidisciplinary team, using a laser-based perfusion system, successfully measured the progressionof vascular stiffness, an early sign of atherosclerosis, in the aortas of mice deficient in apolipoprotein E. Additional studies, performed incollaboration with the Center for Biologic Imaging, simultaneously identified pathologic inflammatory and immune responses within the vesselwall during progression of the disease. These advances can now be extended to investigate atherosclerosis in mouse models of lupus and otherhuman vascular disorders and to identify potential targets for therapeutic intervention in humans.SELECTED SCHOLARLY ACTIVITIESStudy sections (excluding ad hoc review), editorial boards, and other honorsGrant ReviewJoseph M. Ahearn NIH NIAMS Special Emphasis Panel, Chair: ZAR MLB-L 01 (K awards), 2006, Dept. of Veterans Affairs - Merit Review Board forImmunology, Wellcome Trust Scientific Reviewer, Lupus Panel; Department of Defense; Scientific Peer Advisory and Review NHLBI Study Section,Member, 200758 Better medicine through research and education.
2007Eswar Krishnan, Member-Scientific Advisory Council, Study Section A. REF ( American College of Rheumatology)C. Kent Kwoh, National Institutes of Health, Neurology, Aging and Musculoskeletal Epidemiology (NAME) Study section, MemberSusan Manzi, NIH/CICS Study Section, 2005-present, NIAMS Clinical Trial “Prevention of Cardiovascular Complications in Pediatric SLE:Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)Editorial boardsJoseph M. Ahearn, Executive Editor, Clinical and Translational Science, 2007 ( a new journal to be launched in 2007)C. Kent Kwoh, Associate Editor, Arthritis Care and ResearchSusan Manzi, Section Editor, Current Rheumatology Reports, SLEOtherJoseph M. Ahearn, Lupus Panel; American Institute of Biological Sciences (AIBS) and The United States Army Medical Research and MaterialCommand (USAMRMC) (Department of Defense); Scientific Peer Advisory and Review Services; Peer Reviewed Medical Research Program, 2006Faculty of 1000 Biology: Pharmacology & Drug Discovery; Immunopharmacology & Hematologic Pharmacology, 2006-present, Plenary SessionChair; First Lillehammer Biomarker Meeting, Lillehammer, Norway, 2007Dana P. Ascherman, American College of Rheumatology Abstract Review Committee – Myositis SectionC. Kent Kwoh, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Arthritis Data Workgroup, VARheumatology Consortium, Quality Indicators Committee, American College of Rheumatology (ACR), Board of Directors, Osteoarthritis ResearchSociety International (OARSI), Annual Meeting Planning Committee and Treatment Guidelines Committee,Chester V. Oddis, The Myositis Association, Research/Grant Review CommitteeSusan Manzi, Data Safety Monitoring Board, Duke University (Chairperson), 2001-present, NIAMS Intramural Program for SLE Clinical Trials(Chairperson), Data Safety Monitoring Board, 2002-present ,Abbott Scholar Award in Rheumatic Diseases Scientific Board 2002-present,Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CANOIS)Thomas A. Medsger, Jr., Physician Achievement Award, Arthritis Foundation Western Pennsylvania Chapter, 2006, Scleroderma Foundation,Western PA Chapter, Board of Directors and Treasurer, Samuel & Emma Winters Foundation, Executive Committee, Grants Review Committee,Co-ChairChester V. Oddis, Western PA Chapter, Arthritis Foundation Governing Board, The Myositis Association Medical Advisory Board, Board ofDirectors, American College of Rheumatology Committee on Education, International Myositis Assessment and Clinical Studies (IMACS), Board ofDirectors, The Myositis Association, International Myositis Assessment and Clinical Studies (IMACS) Group and Classification Criteria Project59
Page 1 and 2:
Better medicine through education a
Page 3 and 4:
2007institutions, but we are the on
Page 5 and 6:
2007DIVISION ORGANIZATIONCardiovasc
Page 8: Department of MedicineCARDIOLOGYBar
Page 11 and 12: 200711
Page 13 and 14: 200713
Page 15 and 16: 2007The Center for Clinical Pharmac
Page 17: 200717
Page 20 and 21: Department of MedicineHIGH-IMPACT P
Page 22 and 23: Department of MedicineGASTROENTEROL
Page 24 and 25: Department of MedicineEditorial boa
Page 26 and 27: Department of MedicineGENERAL INTER
Page 28 and 29: Department of MedicineEducator Trai
Page 30 and 31: Department of MedicineC. Bernie Goo
Page 32 and 33: Department of MedicineGERIATRIC MED
Page 34 and 35: Department of Medicineof this work
Page 36 and 37: Department of MedicineHEMATOLOGY/ON
Page 38 and 39: Department of Medicinecellular surv
Page 40 and 41: Department of MedicineINFECTIOUS DI
Page 42 and 43: Department of Medicinefellows with
Page 44 and 45: Department of MedicineSELECTED SCHO
Page 46 and 47: Department of MedicinePULMONARY, AL
Page 48 and 49: Department of Medicinean annual upd
Page 50 and 51: Department of MedicineEditorial Boa
Page 52 and 53: Department of MedicineRENAL-ELECTRO
Page 54 and 55: Department of MedicineDr. Bruns, Kl
Page 56 and 57: Department of MedicineRHEUMATOLOGY
Page 60 and 61: Department of MedicineQUALITY IMPRO
Page 62 and 63: Department of MedicineHouse staff i
Page 64 and 65: Department of MedicineMEDICAL EDUCA
Page 66 and 67: Department of Medicinea liaison bet
Page 68 and 69: Department of Medicineand Translati
Page 70 and 71: Department of MedicineDepartment of
Page 72 and 73: Department of Medicine2007 U.S. NEW
Page 74 and 75: Department of MedicineMEDICINE HOUS
Page 76 and 77: Department of MedicineFellow Medica
Page 78 and 79: Department of Medicine78 Better med
Page 80 and 81: Department of MedicineUNIVERSITY OF
Page 84 and 85: Department of MedicineKEY STATISTIC
Page 86 and 87: Department of MedicineSCHOOL OF MED
Page 90 and 91: Department of MedicineTHE UNIVERSIT
Page 92: Department of MedicineIn preparatio
show all

2009 DOM Annual Report - Department of Medicine - University of ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?